Loading...
RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.
Sort By: Relevancy | Date | Type
Displaying items 13-22 of 22
» View ktuu.com items only
    Jan 30, 2010 | Los Angeles Times

  1. Doctors cautioned on Zyprexa for adolescents

    Booster Shots
    The Federal Drug Administration on Friday issued a warning to doctors that adolescents taking the drug olanzapine have an "increased potential" -- in comparison with adults taking the new-generation antipsychotic drug -- for weight gain and metabolic...
    2. Apr 13, 2009 |Story| Los Angeles Times

  2. Use of atypical antipsychotics for lesser disorders is gaining ground, despite safety concerns

    About a year ago, patients began trooping into the office of UCLA psychiatrist Andrew Leuchter, asking whether an antipsychotic drug called Abilify "might be right for them." Few appeared to be delusional, plagued by hallucinations or suffering fearsome mood swings. Mostly, they were depressed or anxious, and frustrated by the pace of their recovery.
    Los Angeles Times Staff Writer
    About a year ago, patients began trooping into the office of UCLA psychiatrist Andrew Leuchter, asking whether an antipsychotic drug called Abilify "might be right for them." Few appeared to be delusional, plagued by hallucinations or suffering fearsome...

    Tags: Abilify (drug), Prescription Drugs, Adults, Depression Therapy, Risperdal (drug)

    3. May 15, 2006 |Story| Hartford Courant

  3. Slipping Through The System

    The Hartford Courant
    In the 17 months after their son, Eddie, announced he was heading off to fight the war on terror, Margaret and Edward Brabazon of Bensalem, Pa., had held their breath. They were accustomed to holding their breath with the boy they had taken in as a...

    Tags: Crime, Law and Justice, Disasters and Accidents, Kuwait, North Carolina, Mental Health

    4. Jan 16, 2009 |Story| KCPQ-LTV

  4. Washington State Shares In Eli Lilly Settlement

    Washington state has joined with other states and the federal government in reaching an agreement in principle with Eli Lilly and Company to settle allegations it engaged in an off-label marketing campaign to improperly promote the anti-psychotic drug...

    Tags: Lilly Eli & Co, Long Term Care, Regional Authority, Washington (U.S. state), Politics

    5. Sep 3, 2008 |Story| WXIN-LTV

  5. Lilly: Long-acting Zyprexa shows low relapse rate

    Eli Lilly says a longer-lasting version of its best-selling drug Zyprexa delivers a low rate of relapse or discontinuation among schizophrenics. Lilly spokesman Charles McAtee says the long-acting injectable form of Zyprexa shows a relapse rate...

    Tags: Lilly Eli & Co

    6. Oct 21, 2008 |Story| WXIN-LTV

  6. Lilly takes $1.4 B charge related to investigation

    INDIANAPOLIS (AP) - Drug maker Eli Lilly and Co. says it will take a $1.42 billion charge in the third quarter related to an investigation into marketing practices for the anti-psychotic Zyprexa. The company says it is in advanced discussions to settle...

    Tags: Lilly Eli & Co, Washington, DC, Crime, Law and Justice, Pennsylvania, Health

    7. Jan 15, 2009 |Story| WXIN-LTV

  7. Eli Lilly & Co. settles Zyprexa law suit

    Eli Lilly & Co. is pleading guilty to illegally marketing the anti-psychotic drug Zyprexa (zy-PREX'-uh) for an unapproved use. The Indianapolis drugmaker says it will pay $1.42 billion to settle civil suits and end a criminal investigation.        Lilly...

    Tags: Lilly Eli & Co, Crime, Law and Justice, Behavioral Conditions, Alzheimer's Disease, Corporate Crime

    8. Oct 7, 2008 |Story| WXIN-LTV

  8. Eli Lilly settles Zyprexa inquiries in 32 states

    INDIANAPOLIS (AP) - Eli Lilly & Co. says it will pay $62 million to resolve investigations into the marketing and promotion of its anti-psychotic drug Zyprexa in 32 states and Washington, D.C. The payments will be divided between the states, including...

    Tags: Lilly Eli & Co, Patents, Copyrights and Trademarks, Washington, DC, Indiana

    9. Jan 29, 2009 |Story| WXIN-LTV

  9. Eli Lilly reports 4Q loss on ImClone costs

    INDIANAPOLIS (AP) - Indianapolis-based drugmaker Eli Lilly & Co. swung to a fourth-quarter loss on charges from buying cancer-drug maker ImClone Systems Inc. But Lilly's earnings, without acquisition charges, beat analyst estimates despite flat sales and...

    Tags: Lilly Eli & Co, Quarterly or Semiannual Financial Statements, ImClone Systems Incorporated, Earnings Forecasts

    10. Dec 7, 2003 |Story| Los Angeles Times

  10. Harsh reality of 'Osbournes' no laughing matter

    Los Angeles Times Staff Writer
    Week after week, viewers tuning in to the hit reality series "The Osbournes" saw the star of the show in a perpetual stupor. With cameras rolling, Ozzy Osbourne fell on his backside into the surf off Malibu. He passed out during a party at the Beverly...

    Tags: DVDs and Movies, Health Treatments, Celebrities and Health Issues, Forests, Cancer

< Previous • 1  2 
Original site for Zyprexa (drug) topic gallery.